These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30257092)

  • 1. Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer.
    Pulido D; Casadó-Anguera V; Pérez-Benito L; Moreno E; Cordomí A; López L; Cortés A; Ferré S; Pardo L; Casadó V; Royo M
    J Med Chem; 2018 Oct; 61(20):9335-9346. PubMed ID: 30257092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterobivalent Ligand for the Adenosine A
    Pulido D; Casadó-Anguera V; Gómez-Autet M; Llopart N; Moreno E; Casajuana-Martin N; Ferré S; Pardo L; Casadó V; Royo M
    J Med Chem; 2022 Jan; 65(1):616-632. PubMed ID: 34982555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis toward Bivalent Ligands for the Dopamine D
    Qian M; Wouters E; Dalton JAR; Risseeuw MDP; Crans RAJ; Stove C; Giraldo J; Van Craenenbroeck K; Van Calenbergh S
    J Med Chem; 2018 Sep; 61(18):8212-8225. PubMed ID: 30180563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a true bivalent dopamine D
    Qian M; Ricarte A; Wouters E; Dalton JAR; Risseeuw MDP; Giraldo J; Van Calenbergh S
    Eur J Med Chem; 2021 Feb; 212():113151. PubMed ID: 33450620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homobivalent Dopamine D
    Ullmann T; Gienger M; Budzinski J; Hellmann J; Hübner H; Gmeiner P; Weikert D
    ACS Chem Biol; 2021 Feb; 16(2):371-379. PubMed ID: 33435665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine A2A receptor-antagonist/dopamine D2 receptor-agonist bivalent ligands as pharmacological tools to detect A2A-D2 receptor heteromers.
    Soriano A; Ventura R; Molero A; Hoen R; Casadó V; Cortés A; Fanelli F; Albericio F; Lluís C; Franco R; Royo M
    J Med Chem; 2009 Sep; 52(18):5590-602. PubMed ID: 19711895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualization and ligand-induced modulation of dopamine receptor dimerization at the single molecule level.
    Tabor A; Weisenburger S; Banerjee A; Purkayastha N; Kaindl JM; Hübner H; Wei L; Grömer TW; Kornhuber J; Tschammer N; Birdsall NJ; Mashanov GI; Sandoghdar V; Gmeiner P
    Sci Rep; 2016 Sep; 6():33233. PubMed ID: 27615810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivalent approaches and beyond: novel tools for the investigation of dopamine D2 receptor pharmacology.
    Kopinathan A; Scammells PJ; Lane JR; Capuano B
    Future Med Chem; 2016 Jul; 8(11):1349-72. PubMed ID: 27357619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
    Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?
    Carli M; Kolachalam S; Aringhieri S; Rossi M; Giovannini L; Maggio R; Scarselli M
    Curr Neuropharmacol; 2018 Jan; 16(2):222-230. PubMed ID: 28521704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bivalent dopamine D2 receptor ligands: synthesis and binding properties.
    Kühhorn J; Hübner H; Gmeiner P
    J Med Chem; 2011 Jul; 54(13):4896-903. PubMed ID: 21599022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer.
    Ferré S; Bonaventura J; Tomasi D; Navarro G; Moreno E; Cortés A; Lluís C; Casadó V; Volkow ND
    Neuropharmacology; 2016 May; 104():154-60. PubMed ID: 26051403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Characterization of the Imipridone Anticancer Drug ONC201 Reveals a Negative Allosteric Mechanism of Action at the D
    Free RB; Cuoco CA; Xie B; Namkung Y; Prabhu VV; Willette BKA; Day MM; Sanchez-Soto M; Lane JR; Laporte SA; Shi L; Allen JE; Sibley DR
    Mol Pharmacol; 2021 Oct; 100(4):372-387. PubMed ID: 34353882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and binding profile of haloperidol-based bivalent ligands targeting dopamine D(2)-like receptors.
    Salama I; Löber S; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3753-6. PubMed ID: 25047579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A QM protein-ligand investigation of antipsychotic drugs with the dopamine D2 Receptor (D2R).
    Ekhteiari Salmas R; Serhat Is Y; Durdagi S; Stein M; Yurtsever M
    J Biomol Struct Dyn; 2018 Aug; 36(10):2668-2677. PubMed ID: 28805144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dopamine D2 receptor dimer and its interaction with homobivalent antagonists: homology modeling, docking and molecular dynamics.
    Kaczor AA; Jörg M; Capuano B
    J Mol Model; 2016 Sep; 22(9):203. PubMed ID: 27491852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and In Vitro Evaluation of Novel Dopamine Receptor D
    Juza R; Stefkova K; Dehaen W; Randakova A; Petrasek T; Vojtechova I; Kobrlova T; Pulkrabkova L; Muckova L; Mecava M; Prchal L; Mezeiova E; Musilek K; Soukup O; Korabecny J
    Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The action of a negative allosteric modulator at the dopamine D
    Draper-Joyce CJ; Verma RK; Michino M; Shonberg J; Kopinathan A; Klein Herenbrink C; Scammells PJ; Capuano B; Abramyan AM; Thal DM; Javitch JA; Christopoulos A; Shi L; Lane JR
    Sci Rep; 2018 Jan; 8(1):1208. PubMed ID: 29352161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer.
    Guo W; Shi L; Javitch JA
    J Biol Chem; 2003 Feb; 278(7):4385-8. PubMed ID: 12496294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor, Ligand and Transducer Contributions to Dopamine D2 Receptor Functional Selectivity.
    Peterson SM; Pack TF; Caron MG
    PLoS One; 2015; 10(10):e0141637. PubMed ID: 26516769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.